Lung Cancer
Filters
Alecensa (Alectinib) 150mg Capsules | Roche India for ALK+ NSCLC | GLT
Alecensa 150mg India, 56-capsule box — Roche Products India presentation of the second-generation ALK inhibitor
Alecensa (Alectinib) 150mg Capsules | Roche Taiwan China for ALK+ NSCLC | GLT
Alecensa 150mg Taiwan China — regulated-market Roche pack of the second-generation ALK inhibitor
Alecnib (Alectinib) 150mg Capsules 56-Pack | Everest Bangladesh Generic Alecensa | GLT
Alecnib 150mg by Everest Pharmaceuticals Ltd — WHO-GMP Bangladeshi generic alectinib, 56-capsule bottle
Alynni (Alectinib) 150mg Capsules 56-Pack | TLPH Laos Generic Alecensa | GLT
Alynni 150mg by TLPH Tongmeng (Lao) Pharmaceutical — Laotian generic alectinib, 56-capsule bottle
LuciAle (Alectinib) 150mg Capsules 56-Pack | Lucius Laos Generic Alecensa | GLT
LuciAle 150mg by Lucius Pharmaceuticals (Lao) — Laotian generic alectinib, 56 capsules per box
Ailedx (Alectinib) 150mg Capsules 112-Pack | BigBear Laos Generic Alecensa | GLT
Ailedx 150mg by Bigbear Pharmaceutical (Lao) — Lao FDA registered generic alectinib, 112-capsule bottle
Vizimpro (Dacomitinib) 45mg*30's | EGFR Inhibitor for NSCLC | GLT
Pfizer second-generation irreversible EGFR inhibitor, US-sourced
LucoDac (Dacomitinib) 15mg/45mg*30's | Generic EGFR Inhibitor | GLT
Lao generic dacomitinib by Lucius, affordable EGFR-mutated NSCLC therapy
Dacocare (Dacomitinib) 45mg*30's | Generic EGFR Inhibitor | GLT
Lao generic dacomitinib by ElementoPharma, affordable NSCLC therapy
Gilotrif (Afatinib) 40mg Tablets | Boehringer Ingelheim Originator | GLT
International originator afatinib from Boehringer Ingelheim GmbH, Germany
Afanat (Afatinib) 40mg Tablets | Natco Generic EGFR Inhibitor | GLT
Natco generic afatinib for EGFR-mutant NSCLC
Xovoltib (Afatinib) 40mg Tablets | Taiwan Originator | GLT
Taiwan-marketed Boehringer Ingelheim afatinib
Anib (Afatinib) 40mg Tablets | DIL Bangladesh Generic | GLT
DIL generic afatinib for EGFR-mutant NSCLC
LuciAfa (Afatinib) 40mg Tablets | Lucius Laos Generic | GLT
Lucius generic afatinib for EGFR-mutant NSCLC
Gavreto (Pralsetinib) 100mg*60 | Blueprint Medicines USA | GLT
Blueprint Medicines originator pralsetinib — selective RET inhibitor for RET-fusion NSCLC & thyroid cancer
Gavreto (Pralsetinib) 100mg*120 | CStone China NMPA | GLT
China-Mainland Gavreto 100mg — NMPA-approved first selective RET inhibitor, commercialized by CStone
Prasedx (Pralsetinib) 100mg*60 | BigBear Laos Generic | GLT
BigBear Pharmaceutical (Lao) — pralsetinib 100mg generic for RET-fusion NSCLC & thyroid cancer
LuciPral (Pralsetinib) 100mg*120 | Lucius Laos Generic | GLT
Lucius Pharmaceuticals (Lao) — pralsetinib 100mg generic, 120-capsule pack
Regorafenib (Stivarga) 40mg*28's | Bayer Germany Originator | GLT
Bayer Germany originator Stivarga (regorafenib) 40mg 28 tablets for mCRC, GIST & HCC.
Regorafenib (Reganni) 40mg*28's | TLPH Laos Generic | GLT
Reganni — Trans Continental Life Science (TLPH) regorafenib 40mg 28 tablets for mCRC, GIST &...
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling